In vitro Biotransformation, in vivo Efficacy and Pharmacokinetics of Antimalarial Chalcones

4′-n-Butoxy-2,4-dimethoxy-chalcone (MBC) has been described as protecting mice from an otherwise lethal infection with Plasmodium yoelii when dosed orally at 50 mg/kg/dose, daily for 5 days. In contrast, we found that oral dosing of MBC at 640 mg/kg/dose, daily for 5 days, failed to extend the survi...

Ausführliche Beschreibung